Schedule 13D ownership disclosure

ENTERO THERAPEUTICS INC

Common stock, par value $0.0001 per share · CUSIP: 33749P408

Event date: 2025-06-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ali Arif NasirReported CIK 0002072056

    Shares: 250,900.00 · Class: 5.3%

  • Arif Ali IRA Roth

    Shares: 147,900.00 · Class: 3.1%

  • ANARP LLC

    Shares: 82,800.00 · Class: 1.7%

  • ANANRA LLC TRUST

    Shares: 20,200.00 · Class: 0.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-25-019912
Form type
SCHEDULE 13D
Filer
Ali Arif Nasir
CIK
CIK 2072056
Filed
Jun 09, 2025
Reporting period
Jun 02, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub